Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Cited by (251)

Items 201–251 of 251

1. Is synaptic loss a unique hallmark of Alzheimer’s disease?
   Scheff, Stephen W., Neltner, Janna H., Nelson, Peter T. · 2014 · Biochemical Pharmacology
2. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
   Subbarayan, Meena S., Hudson, Charles, Moss, Lauren D., Nash, Kevin R., Bickford, Paula C. · 2020 · Journal of Neuroinflammation
3. Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo
   Lou, Haiyan, Montoya, Susana E., Alerte, Tshianda N.M., Wang, Jian, Wu, Jianjun, Peng, Xiangmin, Hong, Chang-Sook, Friedrich, Emily E., Mader, Samantha A., Pedersen, Courtney J. et al. · 2010 · Journal of Biological Chemistry
4. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
   Gustavsson, Emil K, Follett, Jordan, Trinh, Joanne, Barodia, Sandeep K, Real, Raquel, Liu, Zhiyong, Grant-Peters, Melissa, Fox, Jesse D, Appel-Cresswell, Silke, Stoessl, A Jon et al. · 2024 · The Lancet Neurology
5. Disease model organism for Parkinson disease: <i>Drosophila melanogaster</i>
   Aryal, Binod, Lee, Youngseok · 2019 · BMB Reports
6. Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease
   Mullin, Stephen, Schapira, Anthony H.V. · 2015 · Neurologic Clinics
7. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
   Rojanathammanee, Lalida, Murphy, Eric J, Combs, Colin K · 2011 · Journal of Neuroinflammation
8. Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation
   Breid, Sara, Bernis, Maria E., Babila, Julius T., Garza, Maria C., Wille, Holger, Tamgüney, Gültekin · 2016 · Journal of Virology
9. Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
   Kohl, Zacharias, Winner, Beate, Ubhi, Kiren, Rockenstein, Edward, Mante, Michael, Münch, Martina, Barlow, Carolee, Carter, Todd, Masliah, Eliezer, Winkler, Jürgen · 2012 · European Journal of Neuroscience
10. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies
    Nelson, P. T., Kryscio, R. J., Jicha, G. A., Abner, E. L., Schmitt, F. A., Xu, L. O., Cooper, G., Smith, C. D., Markesbery, W. R. · 2009 · Neurology
11. Parkinsons Disease and other α-Synucleinopathies
    Goedert, Michel · 2001 · Clinical Chemistry and Laboratory Medicine
12. Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation
    Vieira, Bruno Di Marco, Radford, Rowan A., Chung, Roger S., Guillemin, Gilles J., Pountney, Dean L. · 2015 · Frontiers in Cellular Neuroscience
13. Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts
    Braidy, Nady, Gai, Wei-Ping, Xu, Ying Hua, Sachdev, Perminder, Guillemin, Gilles J, Jiang, Xing-Mai, Ballard, J William O, Horan, Martin P, Fang, Zhi Ming, Chong, Beng H et al. · 2013 · Translational Neurodegeneration
14. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
    Stanga, Serena, Caretto, Anna, Boido, Marina, Vercelli, Alessandro · 2020 · International Journal of Molecular Sciences
15. A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
    Pabon, Mibel M., Jernberg, Jennifer N., Morganti, Josh, Contreras, Jessika, Hudson, Charles E., Klein, Ronald L., Bickford, Paula C. · 2012 · PLoS ONE
16. Striatal glutamatergic hyperactivity in Parkinson's disease
    Campanelli, F., Natale, G., Marino, G., Ghiglieri, V., Calabresi, P. · 2022 · Neurobiology of Disease
17. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
    Kumaran, Ravindran, Cookson, Mark R. · 2015 · Human Molecular Genetics
18. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome
    Charlett, A., Dobbs, R. J., Dobbs, S. M., Weller, C., Brady, P., Peterson, D.W. · 2009 · Acta Neurologica Scandinavica
19. Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation
    Kauwe, John S. K., Jacquart, Sarah, Chakraverty, Sumi, Wang, Jun, Mayo, Kevin, Fagan, Anne M., Holtzman, David M., Morris, John C., Goate, Alison M. · 2007 · Annals of Neurology
20. C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders
    Takeda, A., Hashimoto, M., Mallory, M., Sundsumo, M., Hansen, L., Masliah, E. · 2000 · Acta Neuropathologica
21. Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
    Peng, Wesley, Minakaki, Georgia, Nguyen, Maria, Krainc, Dimitri · 2019 · Neurotherapeutics
22. Quantitative neurohistological features of frontotemporal degeneration
    Arnold, Steven E., Han, Li-Ying, Clark, Christopher M., Grossman, Murray, Trojanowski, John Q. · 2000 · Neurobiology of Aging
23. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies
    Permanne, Bruno, Sand, Astrid, Ousson, Solenne, Nény, Maud, Hantson, Jennifer, Schubert, Ryan, Wiessner, Christoph, Quattropani, Anna, Beher, Dirk · 2022 · ACS Chemical Neuroscience
24. Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies
    Hashimoto, Makoto, Masliah, Eliezer · 2003 · Neurochemical Research
25. Basal lamina changes in neurodegenerative disorders
    Nguyen, Benjamin, Bix, Gregory, Yao, Yao · 2021 · Molecular Neurodegeneration
26. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy
    Liu, Jia, Wang, Xue, Lu, Yongquan, Duan, Chunli, Gao, Ge, Lu, Lingling, Yang, Hui · 2017 · Cell Death &amp; Disease
27. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease
    Noureddine, Maher A., Qin, Xue-Jun, Oliveira, Sofia A., Skelly, Tara J., van der Walt, Joelle, Hauser, Michael A., Pericak-Vance, Margaret A., Vance, Jeffery M., Li, Yi-Ju · 2005 · Human Genetics
28. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
    Kawahata, Ichiro, Fukunaga, Kohji · 2020 · International Journal of Molecular Sciences
29. α‐Synuclein promotes clathrin‐mediated NMDA receptor endocytosis and attenuates NMDA‐induced dopaminergic cell death
    Cheng, Furong, Li, Xin, Li, Yaohua, Wang, Chaodong, Wang, Tao, Liu, Guangwei, Baskys, Andrius, Uéda, Kenji, Chan, Piu, Yu, Shun · 2011 · Journal of Neurochemistry
30. Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein
    Wongkongkathep, Piriya, Han, Jong Yoon, Choi, Tae Su, Yin, Sheng, Kim, Hugh I., Loo, Joseph A. · 2018 · Journal of the American Society for Mass Spectrometry
31. Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
    González-Hernández, Tomás · 2010 · Frontiers in Neuroanatomy
32. Cholesterol homeostasis failure in the brain: Implications for synaptic dysfunction and cognitive decline
    Segatto, Marco, Leboffe, Loris, Trapani, Laura, Pallottini, Valentina · 2014 · Current Medicinal Chemistry
33. Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
    Cebrián, Carolina, Loike, John D., Sulzer, David · 2014 · Current Topics in Behavioral Neurosciences
34. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
    Eteleeb, Abdallah M., Novotny, Brenna C., Tarraga, Carolina Soriano, Sohn, Christopher, Dhungel, Eliza, Brase, Logan, Nallapu, Aasritha, Buss, Jared, Farias, Fabiana, Bergmann, Kristy et al. · 2024 · PLOS Biology
35. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
    Yabuki, Yasushi, Matsuo, Kazuya, Kawahata, Ichiro, Fukui, Naoya, Mizobata, Tomohiro, Kawata, Yasushi, Owada, Yuji, Shioda, Norifumi, Fukunaga, Kohji · 2020 · International Journal of Molecular Sciences
36. Early and persistent expression of phosphorylated α-synuclein in the enteric nervous system of A53T mutant human α-synuclein transgenic mice
    Bencsik, Anna, Muselli, Letizia, Leboidre, Mikael, Lakhdar, Latifa, Baron, Thierry · 2014 · Journal of Neuropathology &amp; Experimental Neurology
37. Rifampicin Attenuates the MPTP-Induced Neurotoxicity in Mouse Brain
    Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H., Hara, H. · 2006 · Brain Research
38. Relevance of chronic stress and the two faces of microglia in Parkinson's disease
    Herrera, Antonio J., Espinosa-Oliva, Ana M., Carrillo-Jiménez, Alejandro, Oliva-Martín, María J., García-Revilla, Juan, García-Quintanilla, Alberto, de Pablos, Rocío M., Venero, José L. · 2015 · Frontiers in Cellular Neuroscience
39. C/EBPβ/δ-secretase signaling mediates Parkinson’s disease pathogenesis via regulating transcription and proteolytic cleavage of α-synuclein and MAOB
    Wu, Zhourui, Xia, Yiyuan, Wang, Zhihao, Su Kang, Seong, Lei, Kecheng, Liu, Xia, Jin, Lingjing, Wang, Xiaochuan, Cheng, Liming, Ye, Keqiang · 2021 · Molecular Psychiatry
40. Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells
    Li, Wen-Jing, Jiang, Hong, Song, Ning, Xie, Jun-Xia · 2010 · Neuroscience Bulletin
41. Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease
    Andersen, Julie K. · 2003 · Neurotoxicity Research
42. Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson’s disease.
    Bortolozzi, Analia, Manashirov, Sharon, Chen, Alon, Artigas, Francesc · 2021 · Pharmacology &amp; Therapeutics
43. Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson’s Disease: Current Understanding and Knowledge Gaps
    Huntington, Taylor E, Srinivasan, Rahul · 2021 · Aging and disease
44. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
    Siokas, Vasileios, Aloizou, Athina-Maria, Tsouris, Zisis, Liampas, Ioannis, Liakos, Panagiotis, Calina, Daniela, Docea, Anca Oana, Tsatsakis, Aristidis, Bogdanos, Dimitrios P., Hadjigeorgiou, Georgios M. et al. · 2021 · Journal of Clinical Medicine
45. Exploring the connection between the gut microbiome and parkinson's disease symptom progression and pathology: implications for supplementary treatment options
    Chan, Dennis G., Ventura, Katelyn, Villeneuve, Ally, Du Bois, Paul, Holahan, Matthew R. · 2022 · Journal of Parkinson's Disease
46. Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice
    Jiao, Lingling, Du, Xixun, Jia, Fengju, Li, Yong, Zhu, Dexiao, Tang, Tinging, Jiao, Qian, Jiang, Hong · 2021 · Neurobiology of Aging
47. Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome
    Iqbal, Anila, Baldrighi, Marta, Murdoch, Jennifer N., Fleming, Angeleen, Wilkinson, Christopher J. · 2020 · Biology Open
48. Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
    Ferrantelli, Flavia, Chiozzini, Chiara, Leone, Patrizia, Manfredi, Francesco, Federico, Maurizio · 2020 · Pharmaceutics
49. Neuropathology of dementia
    Kim, Eun-Joo, Vatsavayai, Sarat, Seeley, William W. · 2016 · The Behavioral Neurology of Dementia
50. Human iPSC Models in Drug Discovery: Opportunities and Challenges
    Silva, M.C., Cross, A., Brandon, N.J., Haggarty, S.J. · 2017 · Comprehensive Medicinal Chemistry III
51. The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases
    Lane-Donovan, Courtney, Paredes, Mercedes, Kao, Aimee W. · 2025 · Progress in Neurobiology